Table 1.
Correlations of CYP19A1 expression with estrogen-related protein expressions and clinicopathological features
| Value | CYP19A1 in CCA | ||
|---|---|---|---|
| Low (n = 29) | High (n = 45) | #P value | |
| Age | |||
| < 57 | 15 | 21 | 0.671 |
| ≥ 57 | 14 | 24 | |
| Sex | |||
| Male | 20 | 31 | 0.994 |
| Female | 9 | 14 | |
| Metastasis status | |||
| Non-metastasis | 21 | 12 | < 0.001 |
| Metastasis | 8 | 33 | |
| Histological type | |||
| Tubular | 12 | 27 | 0.117 |
| Papillary | 17 | 18 | |
| Estrogen-related protein | |||
| ERα | |||
| Low | 7 | 9 | 0.673 |
| High | 22 | 36 | |
| ERβ | |||
| Low | 18 | 19 | 0.096 |
| High | 11 | 26 | |
| GPR30 | |||
| Low | 23 | 23 | 0.015 |
| High | 6 | 22 | |
| TFF1 | |||
| Low | 17 | 18 | 0.117 |
| High | 12 | 27 | |
#P value was analyzed by Pearson’s chi-square test